Stoke Therapeutics, Inc. (STOK)

CIK 1623526 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Stoke Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026SCHEDULE 13G/A0000315066-26-002860
Nov 4, 202640001780088-26-000025
Nov 3, 202610-Q0001193125-26-445326
Oct 29, 20268-K0001193125-26-437775
Oct 21, 20261440001950047-26-010349
Oct 2, 202640001780088-26-000023
Oct 2, 202640001966716-26-000014
Oct 2, 20261440001950047-26-010004
Sep 30, 2026SCHEDULE 13G0000921895-26-002685
Sep 25, 202640001685994-26-000009
Sep 25, 20268-K0001193125-26-402820
Sep 25, 202630001685994-26-000007
Sep 3, 202640001780088-26-000021
Aug 18, 202640001522780-26-000007
Aug 18, 202640001966716-26-000012
Aug 18, 202640001780088-26-000019
Aug 14, 2026SCHEDULE 13G/A0000902664-26-003525
Aug 12, 2026SCHEDULE 13G/A0000947263-26-000071
Aug 6, 2026SCHEDULE 13G/A0000315066-26-002141
Aug 5, 202640001780088-26-000017
Aug 3, 20268-K0001193125-26-330804
Aug 3, 202610-Q0001193125-26-330557
Aug 3, 2026424B50001193125-26-330792
Aug 3, 20261440001950047-26-007565
Aug 3, 2026S-80001193125-26-330706